Accordingly, the NLRP3 inflammasome pathway as well as the resulting production of the master cytokine IL-1ß might contribute to clinically relevant consequences of inflammation in obesity. This evidence concerns the gene IL1B and obesity due to melanocortin 4 receptor deficiency.